Houston Methodist Hospital

Event

Cytopathology and Small Biopsy Update

presented by Houston Methodist Hospital

17 others would like to attend.

Register Now

Notification icon Saturday, February 18, 2023 7:15 AM - 5:15 PM America/Chicago

Location Icon 6670 Bertner Avenue, Houston, Texas 77030

Event info

OVERVIEW

Physicians and cytologists need the most up to date knowledge and strategies in pathology and cytopathology in order to provide the most appropriate ancillary testing for their patients and for guiding patient management. With the current update, attendees will learn the various new evidence-based reporting terminologies or updates to previously existing ones.. This will enable them to assess the patient’s risk of malignancy specifically regarding findings in thyroid, respiratory, urinary, body fluid, and pancreatobiliary cytology and small biopsies. By understanding these new site-specific reporting systems, attendees will know the risk of malignancy associated with each reporting category and appropriate ancillary testing; and therefore better guide management of their patients The World Health Organization under the guidance of the International Academy of Cytology and other organizations is currently in the process of publishing cytopathology reporting terminology. An update/status on these will be provided. Additionally, digital pathology and other new technologies, as they apply specifically to cytology and small specimens, will be discussed. New developments in the field that will impact patient care in the future will also be presented.

TARGET AUDIENCE

Physicians, residents and fellows, cytopathologists, cytotechnologists, pathologists, residents and fellows in pathology, ENT, endocrinology, urology and internal medicine.

LEARNING OBJECTIVES

At the conclusion of this activity, the participant should be able to: 

  • Describe the diagnosis molecular testing and management of thyroid nodules and update to the Thyroid Bethesda System Reporting Terminology.
  • Understand how the risk of malignancy in reporting terminology is affected by the inclusion of non-invasive follicular thyroid neoplasm with papillary like features (NIFTP).
  • Understand respiratory, pancreatobiliary, urinary and body fluid cytology reporting terminology, risk of malignancy associated with the various reporting categories, and new ancillary testing options
  • Apply appropriate molecular testing to small specimens for management of lesions of lung, pancreaticobiliary, urinary tract and other systems
  • Participants should be able to define risk stratification based on cytology and HPV testing in gynecologic cytology
  • Be current on the role of HPV testing in head and neck cancer and Lower anogenital tract reporting terminology

ACCREDITATION

Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Houston Methodist designates this Live activity for a maximum of 6.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.

Faculty
  • Dina Mody

    Course Director

  • Mary Schwartz

    Course Director

17 others would like to attend.

Register Now


0 Comments
Login to view comments. Click here to Login